Second generation direct-acting antiviral (DAAs) Treatment on HCV+ patients: Patient reported outcomes (PROs) and psychiatric symptoms in a real world setting sample. - Moneglia, M.; Santangelo, A.; Burian, I.; Gragnani, L.; Elisa, F.; Quargnolo, M.; Pallanti, S.; Zignego, A.L. (European Psychiatry, 2017)